Akiyuki Uzawa Selected Research

Akiyuki Uzawa Research Topics

Disease

43	Myasthenia Gravis 06/2024 - 12/2009
21	Neuromyelitis Optica (Devic's Disease) 01/2023 - 12/2009
12	Multiple Sclerosis 01/2020 - 12/2009
8	Inflammation (Inflammations) 01/2021 - 05/2013
7	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 05/2013
7	Nervous System Diseases (Neurological Disorders) 04/2022 - 12/2010
6	Thymoma (Thymic Carcinoma) 11/2021 - 06/2015
5	Disease Progression 01/2024 - 07/2019
3	Neoplasms (Cancer) 08/2022 - 01/2016
3	Optic Neuritis (Retrobulbar Neuritis) 04/2022 - 01/2011
2	Muscle Weakness 01/2024 - 01/2017
2	Atrophy 01/2023 - 08/2019
2	Neuralgia (Stump Neuralgia) 09/2022 - 01/2011
2	Cerebral Infarction 08/2022 - 01/2018
2	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 12/2005
2	Diabetes Mellitus 01/2021 - 12/2020
2	Ischemic Stroke 01/2021 - 12/2020
2	Transient Ischemic Attack 01/2021 - 01/2018
2	Atherosclerosis 01/2021 - 12/2020
2	Myelitis 11/2020 - 06/2013
2	Thymus Hyperplasia 11/2016 - 01/2015
1	Immune System Diseases (Immune Disorders) 07/2023
1	Vascular Remodeling 01/2023
1	Seizures (Absence Seizure) 09/2022
1	Adenomyosis 08/2022
1	Stroke (Strokes) 08/2022
1	Brain Infarction 08/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2022
1	Inclusion Body Myositis 04/2022
1	Muscular Diseases (Myopathy) 04/2022
1	Anaphylaxis (Anaphylactic Shock) 02/2022
1	Cryptococcal Meningitis 08/2021
1	Neuromuscular Junction Diseases 01/2021
1	Aspiration Pneumonia 01/2021
1	Myocardial Infarction 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Esophageal Squamous Cell Carcinoma 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2020
1	Neuroinflammatory Diseases 11/2020
1	Nausea 01/2020
1	Vertigo (Positional Vertigo) 01/2020
1	Progressive Multifocal Leukoencephalopathy 05/2018

Drug/Important Bio-Agent (IBA)

14	Cholinergic ReceptorsIBA 06/2024 - 12/2009
13	AutoantibodiesIBA 05/2024 - 07/2015
11	AntibodiesIBA 11/2023 - 07/2015
11	Interleukin-6 (Interleukin 6)IBA 09/2022 - 12/2009
8	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 01/2015
8	CytokinesIBA 11/2023 - 12/2010
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2005
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2009
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2024 - 01/2017
5	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
4	eculizumab FDA Link 04/2024 - 06/2019
4	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2020
4	AntigensIBA 08/2022 - 12/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2011
3	Complement System Proteins (Complement)IBA 04/2024 - 01/2020
3	CD40 Ligand (CD40L)IBA 11/2023 - 01/2017
3	ChemokinesIBA 04/2022 - 12/2010
3	Fingolimod Hydrochloride (FTY720)FDA Link 08/2021 - 01/2018
3	SteroidsIBA 01/2021 - 01/2019
3	HMGB1 Protein (HMG1)IBA 01/2021 - 05/2013
2	glucose-mannose-glucoseIBA 04/2024 - 01/2020
2	Phosphotransferases (Kinase)IBA 12/2023 - 11/2023
2	Methylprednisolone FDA LinkGeneric 01/2023 - 07/2019
2	Intravenous Immunoglobulins (IVIG)FDA Link 02/2022 - 05/2021
2	Complementary DNA (cDNA)IBA 01/2021 - 12/2020
2	AlbuminsIBA 01/2018 - 07/2017
2	InterleukinsIBA 06/2017 - 12/2009
2	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 11/2016 - 04/2016
1	muskIBA 06/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2024
1	Semaphorins (Semaphorin)IBA 05/2024
1	ravulizumabIBA 04/2024
1	SuspensionsIBA 11/2023
1	Indicators and Reagents (Reagents)IBA 06/2023
1	LeptinIBA 01/2023
1	Growth Differentiation Factor 2IBA 01/2023
1	LigandsIBA 01/2023
1	interleukin-21 (interleukin 21)IBA 01/2023
1	satralizumabIBA 09/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 09/2022
1	Monoclonal AntibodiesIBA 09/2022
1	PTX3 proteinIBA 01/2022
1	B-Cell Activation Factor ReceptorIBA 11/2021
1	CXC ChemokinesIBA 11/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Recombinant ProteinsIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Protein Subunits (Protein Subunit)IBA 01/2020
1	Complement Inactivating AgentsIBA 12/2019
1	Natalizumab (Tysabri)FDA Link 05/2018

Therapy/Procedure

6	Therapeutics 12/2022 - 01/2017
3	Activities of Daily Living (ADL) 06/2023 - 12/2019
3	Immunotherapy 01/2023 - 12/2022
2	Duration of Therapy 08/2019 - 05/2018
1	Biological Therapy 01/2023
1	Hysterectomy 08/2022
1	Blood Component Removal (Apheresis) 02/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021